European Cytokine Network
Volume 8, issue 3, September 1997
Volume 8, issue 3, September 1997
Synthèses
Natural killer T cells: a potent cytokine-producing cell population
(p.229-37)
M.C. Leite-de-Moraes and M. Dy
Free Access
Quantification of cytokine transcripts using polymerase chain reaction
(p.239-44)
S. Delassus
Free Access
Articles originaux
Hepatocyte-derived cell lines express a functional receptor for cardiotrophin-1
(p.245-52)
O . Robledo, C. Guillet, S. Chavalier, M. Fourcin, J. Froger, A. Pouplard-Barthelaix, D. Pennica and H. Gascan
Free Access
Tumor necrosis factor production capacity as a potentially useful parameter to monitor disease activity in multiple sclerosis
(p.253-7)
M. Chofflon, S. Roth, C. Juillard, A.M. Paunier, P. Juillard, D. Degroote and G.E. Grau
Free Access
Regression of Morris hepatoma in response to intralesional treatment with tumor necrosis factor muteins
(p.259-63)
S. Terlikowski, S. Sulkowski and H. F. Nowak
Free Access
Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1
(p.265-9)
G . Pentón-Rol, N. Polentarutti, M. Sironi, S. Saccani, M. Introna, A. Mantovani
Free Access
Expression of monocyte chemotactic protein-3 in human monocytes and endothelial cells
(p.271-4)
N . Polentarutti, M . I n t rona, S. Sozzani, R. Mancinelli, G. Mantovani, A. Mantovani
Free Access
Host’s immune response in electrotherapy of murine tumors by direct current
(p.275-9)
D. Miklav[ci[c, D. An, J. Belehradek and L.M. Mir
Free Access
Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus
(p.281-6)
E . Robak, A. Sysa-Jedrze-jowska, H. Stepieen and T. Robak
Free Access
Compte rendu de congrès
Cytokines: a pharmacologically-oriented introduction
(p.289-90)
P. Ghezzi
Free Access
Clinical pharmacology of cytokines
(p.291-3)
B. Rouveix
Free Access
Blocking interleukin-1 and tumor necrosis factor in disease
(p.294-6)
C.A. Dinarello
Free Access
Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action
(p.297-300)
M . Feldmann, F. Brennan, E. Paleolog, P. Taylor, R.N. Maini
Free Access
Interleukin-10 as an anti-stress cytokine
(p.301-2)
M. Goldmann, P. Stordeur
Free Access
Clinical development of interleukin-10
(p.303-4)
A. Lebeaut, J.-J. Garaud
Free Access
Biological properties and therapeutic applications of interleukin-12
(p.305-7)
G. Trinchieri
Free Access
Erythropoietin: from molecular biology to clinical use
(p.308-10)
C. Lacombe
Free Access
Thrombopoietin (Mpl ligand) and the regulation of platelet production
(p.311-4)
K. Cohen-Solal, N. Debili, W. Vainchenker, F. Wendling
Free Access
Immunointervention based on Th2-type cytokines in HIV infection
(p.315-6)
P. Galanaud, R. Fior, F. Boue, D. Émilie
Free Access
Cytokines in severe infections: from pathophysiology to clinical applications
(p.317-8)
M.P. Glauser
Free Access
Interferon alpha in hepatitis C: a cytokine for reducing fibrosis progression
(p.319-20)
T. Poynard
Free Access
Cytokines as prognostic and therapeutic tools in human cancer
(p.321-2)
W.H. Fridman, A. Berger, P.H. Cugnenc, E. Tartour
Free Access
GP130 cytokines, interferon, survival and proliferation of human myeloma cells
(p.323)
B. Klein
Free Access
The dream of effective cytokine-based tumor vaccines
(p.324-5)
G. Forni, K. Boggio, M. Giovarelli, F. Cavallo
Free Access